NeuroMetrix - Stock Price History | NURO

Historical daily share price chart and data for NeuroMetrix since 2019 adjusted for splits. The latest closing stock price for NeuroMetrix as of September 17, 2019 is 0.38.
  • The all-time high NeuroMetrix stock closing price was 46510.67 on May 09, 2006.
  • The NeuroMetrix 52-week high stock price is 1.39, which is 265.8% above the current share price.
  • The NeuroMetrix 52-week low stock price is 0.32, which is 15.8% below the current share price.
  • The average NeuroMetrix stock price for the last 52 weeks is 0.82.
NeuroMetrix Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 1.3121 1.7500 2.0800 0.6785 0.7600 -56.04%
2017 3.2733 5.7640 6.7664 1.5100 1.7290 -70.74%
2016 12.2632 14.8800 16.6080 5.1600 5.9088 -62.70%
2015 35.5508 61.4400 61.4400 15.8400 15.8400 -74.62%
2014 64.0445 93.4400 93.4400 50.2432 62.4000 -33.22%
2013 69.1510 88.3023 100.1600 48.0000 93.4400 12.55%
2012 137.9607 253.3893 282.1836 83.0234 83.0234 -65.40%
2011 487.6891 692.1903 724.3182 239.9520 239.9520 -69.35%
2010 1408.8229 2848.9083 2848.9083 581.4122 782.9316 -72.47%
2009 2311.0293 898.2007 3938.2645 783.0467 2844.3022 183.91%
2008 2855.7579 11031.7469 12632.3865 598.8005 1001.8392 -90.54%
2007 10794.7867 16697.3204 16697.3204 8348.6602 10594.1619 -38.30%
2006 32036.3061 32243.1015 46510.6739 15568.8119 17169.4515 -45.34%
2005 23785.5660 12977.8483 42871.8096 10421.4310 31413.9931 132.17%
2004 10486.4324 9269.8917 13530.5872 8509.8757 13530.5872 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.005B $0.016B
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00